要论 中国医药 行业的“并购之王”,根正苗红的 华润医药 必有一席之地。从 华润三九 、 江 中药 业 、 昆药集团 到 东阿阿胶 、 天士力 ,华润医药几乎将各个细分领域的龙头公司都一把揽入怀中,共有成员企业超过700家,是当之无愧的中国非处方药“一哥”。最新年报显示,华润医药截至2024年末,总资产高达2578亿,报告期内实现营业收入2576.73亿元,同比增加4.77%;归母净利润33.51...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.